These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
296 related articles for article (PubMed ID: 12453880)
21. Expression of vascular endothelial growth factor and its receptors KDR and Flt-1 in gastric cancer cells. Zhang H; Wu J; Meng L; Shou CC World J Gastroenterol; 2002 Dec; 8(6):994-8. PubMed ID: 12439912 [TBL] [Abstract][Full Text] [Related]
22. MMAC/PTEN tumor suppressor gene regulates vascular endothelial growth factor-mediated angiogenesis in prostate cancer. Koul D; Shen R; Garyali A; Ke LD; Liu TJ; Yung WK Int J Oncol; 2002 Sep; 21(3):469-75. PubMed ID: 12168088 [TBL] [Abstract][Full Text] [Related]
23. Blockage of the vascular endothelial growth factor stress response increases the antitumor effects of ionizing radiation. Gorski DH; Beckett MA; Jaskowiak NT; Calvin DP; Mauceri HJ; Salloum RM; Seetharam S; Koons A; Hari DM; Kufe DW; Weichselbaum RR Cancer Res; 1999 Jul; 59(14):3374-8. PubMed ID: 10416597 [TBL] [Abstract][Full Text] [Related]
24. VEGF receptors are differentially expressed by neuroblastoma cells in culture. Beierle EA; Dai W; Langham MR; Copeland EM; Chen MK J Pediatr Surg; 2003 Mar; 38(3):514-21. PubMed ID: 12632379 [TBL] [Abstract][Full Text] [Related]
25. Taxotere and vincristine inhibit the secretion of the angiogenesis inducing vascular endothelial growth factor (VEGF) by wild-type and drug-resistant human leukemia T-cell lines. Avramis IA; Kwock R; Avramis VI Anticancer Res; 2001; 21(4A):2281-6. PubMed ID: 11724283 [TBL] [Abstract][Full Text] [Related]
26. Distortion of autocrine transforming growth factor beta signal accelerates malignant potential by enhancing cell growth as well as PAI-1 and VEGF production in human hepatocellular carcinoma cells. Sugano Y; Matsuzaki K; Tahashi Y; Furukawa F; Mori S; Yamagata H; Yoshida K; Matsushita M; Nishizawa M; Fujisawa J; Inoue K Oncogene; 2003 Apr; 22(15):2309-21. PubMed ID: 12700666 [TBL] [Abstract][Full Text] [Related]
27. Vascular endothelial growth factor, a possible paracrine growth factor in human acute myeloid leukemia. Fiedler W; Graeven U; Ergün S; Verago S; Kilic N; Stockschläder M; Hossfeld DK Blood; 1997 Mar; 89(6):1870-5. PubMed ID: 9058706 [TBL] [Abstract][Full Text] [Related]
28. Expression of the vascular endothelial growth factor gene is inhibited by p73. Salimath B; Marmé D; Finkenzeller G Oncogene; 2000 Jul; 19(31):3470-6. PubMed ID: 10918605 [TBL] [Abstract][Full Text] [Related]
29. Suppression of tumor angiogenesis and growth by gene transfer of a soluble form of vascular endothelial growth factor receptor into a remote organ. Takayama K; Ueno H; Nakanishi Y; Sakamoto T; Inoue K; Shimizu K; Oohashi H; Hara N Cancer Res; 2000 Apr; 60(8):2169-77. PubMed ID: 10786681 [TBL] [Abstract][Full Text] [Related]
30. The growth inhibition of hepatoma by gene transfer of antisense vascular endothelial growth factor. Kang MA; Kim KY; Seol JY; Kim KC; Nam MJ J Gene Med; 2000; 2(4):289-96. PubMed ID: 10953920 [TBL] [Abstract][Full Text] [Related]
31. Vascular endothelial growth factor isoforms and their receptors are expressed in human osteoarthritic cartilage. Enomoto H; Inoki I; Komiya K; Shiomi T; Ikeda E; Obata K; Matsumoto H; Toyama Y; Okada Y Am J Pathol; 2003 Jan; 162(1):171-81. PubMed ID: 12507900 [TBL] [Abstract][Full Text] [Related]
32. HGF/NK4 inhibited VEGF-induced angiogenesis in in vitro cultured endothelial cells and in vivo rabbit model. Nakabayashi M; Morishita R; Nakagami H; Kuba K; Matsumoto K; Nakamura T; Tano Y; Kaneda Y Diabetologia; 2003 Jan; 46(1):115-23. PubMed ID: 12637990 [TBL] [Abstract][Full Text] [Related]
33. A murine vascular endothelial growth factor antibody inhibits in vivo growth of human Caki-I renal adenocarcinoma. Dagnaes-Hansen F; Rasmussen LM; Tilton R; Denner L; Flyvbjerg A Anticancer Res; 2003; 23(2B):1625-30. PubMed ID: 12820432 [TBL] [Abstract][Full Text] [Related]
35. Neuropilin-1 on hematopoietic cells as a source of vascular development. Yamada Y; Oike Y; Ogawa H; Ito Y; Fujisawa H; Suda T; Takakura N Blood; 2003 Mar; 101(5):1801-9. PubMed ID: 12406894 [TBL] [Abstract][Full Text] [Related]
36. Angiotensin-I-converting enzyme inhibitors may be an alternative anti-angiogenic strategy in the treatment of liver fibrosis and hepatocellular carcinoma. Possible role of vascular endothelial growth factor. Yoshiji H; Kuriyama S; Fukui H Tumour Biol; 2002; 23(6):348-56. PubMed ID: 12677092 [TBL] [Abstract][Full Text] [Related]